Nutra Pharma Corp.
NPHC
$0.00
$0.00100.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -260.70K | -367.10K | -426.90K | -243.10K | -278.50K |
| Total Depreciation and Amortization | 23.00K | 22.60K | 22.20K | 21.80K | 25.00K |
| Total Amortization of Deferred Charges | 34.40K | 38.10K | 37.50K | 21.90K | 27.20K |
| Total Other Non-Cash Items | 58.10K | 75.60K | 60.00K | 41.90K | 27.90K |
| Change in Net Operating Assets | 164.20K | 137.30K | 136.10K | -28.70K | 114.20K |
| Cash from Operations | 19.10K | -93.60K | -171.20K | -186.20K | -84.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 83.60K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.00K | -1.00K | -- | 0.00 | 33.50K |
| Cash from Investing | 34.00K | -1.00K | -- | 83.60K | 33.50K |
| Total Debt Issued | 131.60K | 195.30K | 306.40K | 198.70K | 230.20K |
| Total Debt Repaid | -184.70K | -100.60K | -135.20K | -96.10K | -179.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -53.10K | 94.60K | 171.20K | 102.60K | 50.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | -- |